ストックスクリーナーアプリを入手
8.99
1.24%
0.11
プレマーケット:
8.30
-0.69
-7.68%
前日終値:
$8.88
開ける：
$9.03
24時間の取引高:
107.49K
Relative Volume:
1.50
時価総額：
$467.73M
収益：
-
当期純損益:
$-32.32M
株価収益率:
-14.50
EPS:
-0.62
ネットキャッシュフロー:
$-36.14M
1週間 パフォーマンス:
+9.77%
1か月 パフォーマンス:
+31.24%
6か月 パフォーマンス:
-18.64%
1年 パフォーマンス:
+53.68%
1日の値動き範囲:
$8.5901
$9.33
1週間の範囲:
$8.25
$9.33
52週間の値動き範囲:
$5.67
$14.99
Gh Research Plc Stock (GHRS) Company Profile
GHRS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GHRS
Gh Research Plc
|
8.99 | 467.73M | 0 | -32.32M | -36.14M | -0.62 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Gh Research Plc Stock (GHRS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-08-16 | 開始されました | H.C. Wainwright | Buy |
| 2022-06-16 | 開始されました | ROTH Capital | Buy |
Gh Research Plc (GHRS) 最新ニュース
GH Research PLC (NASDAQ:GHRS) Sees Large Increase in Short Interest - MarketBeat
How the (GHRS) price action is used to our Advantage - Stock Traders Daily
GH Research (NASDAQ:GHRS) Earns “Buy” Rating from HC Wainwright - Defense World
Cormark Issues Negative Outlook for Hudbay Minerals Earnings - Defense World
What is Zacks Research’s Forecast for HALO Q3 Earnings? - Defense World
Equities Analysts Offer Predictions for APOG FY2025 Earnings - Defense World
Jane Street Group LLC Cuts Stock Holdings in Columbia Research Enhanced Value ETF (NYSEARCA:REVS) - Defense World
Harmonic (NASDAQ:HLIT) Rating Lowered to Equal Weight at Barclays - Defense World
Medican Enterprises (OTCMKTS:MDCN) Shares Cross Above Fifty Day Moving Average – Should You Sell? - Defense World
Digital Turbine (NASDAQ:APPS) Shares Cross Above 50 Day Moving Average – Should You Sell? - Defense World
Barclays PLC Purchases Shares of 3,960 American Outdoor Brands, Inc. (NASDAQ:AOUT) - Defense World
Barclays PLC Purchases New Shares in Innovator U.S. Equity Buffer ETF – March (BATS:BMAR) - Defense World
Barclays PLC Invests $40,000 in FT Vest U.S. Equity Deep Buffer ETF – July (BATS:DJUL) - Defense World
Barclays PLC Invests $35,000 in VTEX (NYSE:VTEX) - Defense World
Barclays PLC Purchases 37,347 Shares of MarketWise, Inc. (NASDAQ:MKTW) - Defense World
Barclays PLC Has $39,000 Holdings in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
11,475 Shares in NeoVolta Inc. (NASDAQ:NEOV) Acquired by Barclays PLC - Defense World
Barclays PLC Takes Position in Myomo, Inc. (NYSEAMERICAN:MYO) - Defense World
American Realty Investors, Inc. (NYSE:ARL) Shares Bought by Barclays PLC - Defense World
Barclays PLC Increases Stock Holdings in Angi Inc. (NASDAQ:ANGI) - Defense World
ProShares UltraPro QQQ (NASDAQ:TQQQ) Shares Sold by Barclays PLC - Defense World
GH Research reports progress in depression treatment trials By Investing.com - Investing.com Australia
GH Research (NASDAQ:GHRS) Earns "Buy" Rating from HC Wainwright - MarketBeat
GH Research says completed all FDA requests to address IND hold - TipRanks
GH Research reports progress in depression treatment trials - Investing.com India
GH Research announces primary endpoint met in two Phase 2a PoC trials - TipRanks
GH Research Achieves Key Milestones in Depression Trials and Prepares FDA Response - TipRanks
GH Research Announces Primary Endpoint Met in Two Phase 2a POC Trials with GH001 and Completion of All FDA Requests to Address IND Hold with No Findings of Respiratory Toxicity in Non-Rodents - The Manila Times
GH Research Announces Primary Endpoint Met in Two Phase 2a - GlobeNewswire
GH Research's Depression Drug Achieves 100% Remission in Postpartum Trial, Advances in Bipolar Study - StockTitan
Cedi To End 2025 Around GH¢17.70 To Dollar – Report - Peace FM Online
Learn to Evaluate (GHRS) using the Charts - Stock Traders Daily
Credibility gap closing for psychedelics - BioWorld Online
GH Research (NASDAQ:GHRS) Trading Down 6.7% – Should You Sell? - Defense World
GH Research (NASDAQ:GHRS) Shares Down 6.7%Should You Sell? - MarketBeat
How To Trade (GHRS) - Stock Traders Daily
CBG secures historic GH¢350m capital raise for Kasapreko PLC - Myjoyonline
Fmr LLC Boosts Stake in Vodafone Group Public Limited (NASDAQ:VOD) - Defense World
Fmr LLC Trims Holdings in GH Research PLC (NASDAQ:GHRS) - MarketBeat
3 Top Cybersecurity Stock Picks for 2025 - Head Topics
GH Research PLC Attends Key Neuropsychopharmacology Conference - TipRanks
RA Capital Management L.P. Has $44.73 Million Stock Position in GH Research PLC (NASDAQ:GHRS) - MarketBeat
GH Research PLC (NASDAQ:GHRS) Shares Sold by Verition Fund Management LLC - MarketBeat
GH Research (NASDAQ:GHRS) Stock Price Down 0.3%What's Next? - MarketBeat
GH Research (NASDAQ:GHRS) Stock Price Up 2%Should You Buy? - MarketBeat
GH Research (NASDAQ:GHRS) Trading Down 0.8%Here's What Happened - MarketBeat
(PDF) Neurotrophic and synaptic effects of GnRH and/or GH upon motor function after spinal cord injury in rats - ResearchGate
GH Research (NASDAQ:GHRS) Stock Price Up 1.4%Here's Why - MarketBeat
GH Research’s (GHRS) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
(GHRS) Technical Data - Stock Traders Daily
HC Wainwright Reduces Earnings Estimates for GH Research - Defense World
Gh Research Plc (GHRS) 財務データ
収益
当期純利益
現金流量
EPS
4.81%
大文字化:
|
ボリューム (24 時間):